Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer

Breast Cancer Research and Treatment

Volumn 38, Issue 2, 1996, Pages 217-226

  Escot, Chantai ^a,b   Zhao, Yong ^a,c   Puech, Carole ^a   Rochefort, Henri ^a  

^a INSERM   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c FLORIDA HOSPITAL   (United States)

Author keywords

Breast cancer; Cathepsin D; RNA hybridisation; Stromelysin 3; Urokinase

Indexed keywords

CATHEPSIN D; MESSENGER RNA; STROMELYSIN; UROKINASE;

ADENOCARCINOMA; ARTICLE; BREAST CANCER; CANCER CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METHODOLOGY; PRIORITY JOURNAL; TISSUE SECTION; TRANSCRIPTION REGULATION;

EID: 0029940081     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806676     Document Type: Article

References (30)

1. Gottesman MM: The role of proteases in cancer. In: Gottesman MM (ed) Seminars in Cancer Biology. Saunders Scientific Publications, London, UK, 1990
2. Liotta LA: Tumor invasion and metastases: Role of the basement membrane. Cancer Res 46: 1-7, 1986
3. Blasi F, Vassalli JD, Dano K: Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors. J Cell Biol 104: 801-804, 1987
4. Rochefort H: Oestrogens, proteases and breast cancer. From cell lines to clinical applications. Eur J Cancer 30A: 1583-1586, 1994
5. Rochefort H: Cathepsin D in breast cancer: A tissue marker associated with metastasis. Eur J Cancer 28A: 1780-1783, 1992
6. Duffy MJ, Reilly D, O'Sullivan C et al.: Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res 50: 6827-6829, 1990
7. Jänicke F, Schmitt M, Ulm K, Gössner W, Graeff H: Urokinase-type plasminogen activator antigen and early relapse in breast cancer. Lancet ii: 1049, 1989
8. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990
9. Pyke C, Kristensen P, Ralfkiaer E, Grondahl L, Hansen J, Eriksen J, Blasi F, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138: 1059-1067, 1991
10. Westley G, Rochefort H: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20: 352-362, 1980
11. Cavailles V, Augereau P, Rochefort H: Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TAT dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 90: 203-207, 1993
12. Garcia M, Derocq D, Pujol P, Rochefort H: Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5: 1809-1814, 1990
13. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71: 155-159, 1995
14. Maudelonde T, Brouillet JP, Roger P, Giraudier V, Pages A, Rochefort H: Immunostaining of cathepsin D in breast cancer: Quantification by computerized image analysis and correlation with cytosolic assay. Eur J Cancer 28A: 1686-1691, 1992
15. Roger P, Montcourrier P, Maudelonde T et al.: Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Correlation with cytosolic assay. Human Pathol 25: 863-703, 1994
16. Zhao Y, Escot C, Maudelonde T, Puech C, Rouanet P, Rochefort H: Correlation between mannose-6-phosphate/IG-FII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors. Cancer Res 53: 2901-2905, 1993
17. Page DL, Dupont WD: Indicators of increased breast cancer risk in humans. J Cell Biochem 16G: 175-182, 1992
18. Augereau P, Garcia M, Mattei MG, Cavailles V, Depadova F, Derocq D, Capony F, Ferrara P, Rochefort H: Cloning and sequencing of the 52 K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol 2: 186-192, 1988
19. Escot C, Simony-Lafontaine J, Maudelonde T, Puech C, Pujol H, Rochefort H: Potential value of increased MYC but not ERBB2 RNA levels as a marker of high risk mastopathies. Oncogene 8: 969-974, 1993
20. Basset P, Wolf C, Chambon P: Expression of the stomelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat 24: 185-193, 1993
21. Rømer J, Pyke C, Lund LR, Eriksen J, Kristensen P. Rønne E, Høyer-Hansen G, Danø K, Brünner N: Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion. Int J Cancer 57: 553-560, 1994
22. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692, 1988
23. Liaudet E, Garcia M, Rochefort H: Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 9: 1145-1154, 1994
24. Maudelonde T, Domergue J, Henquel C, Freiss G, Brouillet JP, Frances D, Pujol H, Rochefort H: Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue. Cancer 63: 1265-1270, 1989
25. Maudelonde T, Escot C, Pujol P, Rouanet P, Defrenne A, Brouillet JP, Rochefort H: In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer tumor. Eur J Cancer 30A: 2049-2053, 1994
26. Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N, Kallioniemi OP: Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncology 11: 36-43, 1993
27. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M, Rochefort H: Characterization of the proximal estrogen responsive element of human cathepsin D gene. Mol Endocrinol 8: 693-703, 1994
28. Ossowski L, Clunie G, Masucci MT, Blasi F: In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 115: 1107-1112, 1991
29. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends in Gen 9: 138-141, 1993
30. Garcia M, Salazar-Retana G, Pages A, Richer G, Domergue J, Pages AM, Cavalie G, Martin JM, Lamarque JL, Pau B, Pujol H, Rochefort H: Distribution of the Mr 52,000 oestrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry. Cancer Res 45: 709-716, 1986